References
- Zar HJ. Pneumonia in HIV-infected and uninfected children in developing countries – epidemiology, clinical features and management. Curr Opin Pulm Med. 2004;10:176–182.10.1097/00063198-200405000-00006
- Bozzette SA, Sattler FR, Chiu J, et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med. 1990;323:1451–1457. California Collaborative Treatment Group. 10.1056/NEJM199011223232104
- The National Institutes of Health-University of California Expert. Panel for corticosteroids as adjunctive therapy for pneumocystis pneumonia. consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med. 1990;323:1500–1504.
- Gagnon S, Boota AM, Fischl MA, et al. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. N Engl J Med. 1990;323:1444–1450.10.1056/NEJM199011223232103
- Goussard P, Kling S, Gie RP, et al. CMV pneumonia in HIV-infected ventilated infants. Pediatr Pulmonol. 2010;45:650–655.10.1002/ppul.v45:7
- Shibata S, Nishijima T, Aoki T, et al. A 21-day of adjunctive corticosteroid use may not be necessary for HIV-1-Infected pneumocystis pneumonia with moderate and severe disease. PLoS One. 2015;10:e0138926.10.1371/journal.pone.0138926
- McLaughlin G, Satronjan SV, Schleien CL, et al. Effects of corticosteroids in survival of children with acquired immunodeficiency syndrome and pneumocycis carinni-related respiratory failure. J Pediatr. 1995;126:821–824.10.1016/S0022-3476(95)70421-3
- Alfandari S, Chidiac Ch, Senneville E, et al. Infectious complications of corticosteroids as a adjuvant treatment of pneumomocysitis carinii pneumonia. Med Mal Infect. 1996;26:757–760.10.1016/S0399-077X(96)80030-8
- Newberry L, O’Hare B, Kennedy N, et al. Early use of corticosteroids in infants with a clinical diagnosis of Pneumocystis jiroveci pneumonia in Malawi: a double-blind, randomised clinical trial. Paediatr Int Child Health. 2016 Oct 31.